Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

PMID:
30587516
2.

Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.

Wilson D, Ambler G, Banerjee G, Shakeshaft C, Cohen H, Yousry TA, Al-Shahi Salman R, Lip GYH, Houlden H, Brown MM, Muir KW, Jäger HR, Werring DJ; Clinical relevance of Microbleeds in Stroke (CROMIS-2) collaborators.

J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):320-325. doi: 10.1136/jnnp-2018-318890. Epub 2018 Nov 19.

3.

Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A.

Morrow JM, Evans MRB, Grider T, Sinclair CDJ, Thedens D, Shah S, Yousry TA, Hanna MG, Nopoulos P, Thornton JS, Shy ME, Reilly MM.

Neurology. 2018 Sep 18;91(12):e1125-e1129. doi: 10.1212/WNL.0000000000006214. Epub 2018 Aug 17.

4.

The Diagnostic Value of MRI Pattern Recognition in Distal Myopathies.

Bugiardini E, Morrow JM, Shah S, Wood CL, Lynch DS, Pitmann AM, Reilly MM, Houlden H, Matthews E, Parton M, Hanna MG, Straub V, Yousry TA.

Front Neurol. 2018 Jun 26;9:456. doi: 10.3389/fneur.2018.00456. eCollection 2018.

5.

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.

Wilson D, Ambler G, Shakeshaft C, Brown MM, Charidimou A, Al-Shahi Salman R, Lip GYH, Cohen H, Banerjee G, Houlden H, White MJ, Yousry TA, Harkness K, Flossmann E, Smyth N, Shaw LJ, Warburton E, Muir KW, Jäger HR, Werring DJ; CROMIS-2 collaborators.

Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16. Erratum in: Lancet Neurol. 2018 Jul;17(7):578.

6.

Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned.

Major EO, Yousry TA, Clifford DB.

Lancet Neurol. 2018 May;17(5):467-480. doi: 10.1016/S1474-4422(18)30040-1. Review.

PMID:
29656742
7.

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.

Thust SC, Hassanein S, Bisdas S, Rees JH, Hyare H, Maynard JA, Brandner S, Tur C, Jäger HR, Yousry TA, Mancini L.

Eur Radiol. 2018 Sep;28(9):3779-3788. doi: 10.1007/s00330-018-5351-0. Epub 2018 Mar 23.

8.

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, Li B, Putzki N, Merschhemke M, Häring DA, Wolinsky JS.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):346-356. doi: 10.1002/acn3.534. eCollection 2018 Mar.

9.

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.

Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, Yiannakas MC, Prados F, Ourselin S, Yousry TA, Barkhof F, Ciccarelli O.

Neurology. 2018 Apr 3;90(14):e1183-e1190. doi: 10.1212/WNL.0000000000005256. Epub 2018 Mar 7.

PMID:
29514948
10.

Semi-Automated Analysis of Diaphragmatic Motion with Dynamic Magnetic Resonance Imaging in Healthy Controls and Non-Ambulant Subjects with Duchenne Muscular Dystrophy.

Bishop CA, Ricotti V, Sinclair CDJ, Evans MRB, Butler JW, Morrow JM, Hanna MG, Matthews PM, Yousry TA, Muntoni F, Thornton JS, Newbould RD, Janiczek RL.

Front Neurol. 2018 Jan 26;9:9. doi: 10.3389/fneur.2018.00009. eCollection 2018.

11.

Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yaldizli Ö, Sethi V, Pardini M, Tur C, Mok KY, Muhlert N, Liu Z, Samson RS, Wheeler-Kingshott CAM, Yousry TA, Houlden H, Hardy J, Miller DH, Chard DT.

Mult Scler Relat Disord. 2018 Jan;19:168-170. doi: 10.1016/j.msard.2016.08.006. Epub 2016 Aug 12. No abstract available.

PMID:
29409599
12.

9.4T MR microscopy of the substantia nigra with pathological validation in controls and disease.

Massey LA, Miranda MA, Al-Helli O, Parkes HG, Thornton JS, So PW, White MJ, Mancini L, Strand C, Holton J, Lees AJ, Revesz T, Yousry TA.

Neuroimage Clin. 2017;13:154-163. doi: 10.1016/j.nicl.2016.11.015. Epub 2016 Nov 17.

13.

9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.

Massey LA, Miranda MA, Al-Helli O, Parkes HG, Thornton JS, So PW, White MJ, Mancini L, Strand C, Holton J, Lees AJ, Revesz T, Yousry TA.

Neuroimage Clin. 2016 Nov 17;13:154-163. eCollection 2017.

14.

Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.

De Vita E, Ridgway GR, White MJ, Porter MC, Caine D, Rudge P, Collinge J, Yousry TA, Jager HR, Mead S, Thornton JS, Hyare H.

Neuroimage Clin. 2016 Nov 2;13:89-96. eCollection 2017.

15.

Stability and sensitivity of water T2 obtained with IDEAL-CPMG in healthy and fat-infiltrated skeletal muscle.

Sinclair CD, Morrow JM, Janiczek RL, Evans MR, Rawah E, Shah S, Hanna MG, Reilly MM, Yousry TA, Thornton JS.

NMR Biomed. 2016 Dec;29(12):1800-1812. doi: 10.1002/nbm.3654. Epub 2016 Nov 3.

16.

Functional magnetic resonance imaging in clinical practice: State of the art and science.

Barras CD, Asadi H, Baldeweg T, Mancini L, Yousry TA, Bisdas S.

Aust Fam Physician. 2016 Nov;45(11):798-803.

17.

Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.

Damjanovic D, Valsasina P, Rocca MA, Stromillo ML, Gallo A, Enzinger C, Hulst HE, Rovira A, Muhlert N, De Stefano N, Bisecco A, Fazekas F, Arévalo MJ, Yousry TA, Filippi M.

AJNR Am J Neuroradiol. 2017 Jan;38(1):18-24. doi: 10.3174/ajnr.A4952. Epub 2016 Sep 29.

18.

A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?

Clifford DB, Yousry TA, Major EO.

Mult Scler. 2017 Jun;23(7):934-936. doi: 10.1177/1352458516670735. Epub 2016 Sep 27.

PMID:
27679459
19.

Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.

Ricotti V, Evans MR, Sinclair CD, Butler JW, Ridout DA, Hogrel JY, Emira A, Morrow JM, Reilly MM, Hanna MG, Janiczek RL, Matthews PM, Yousry TA, Muntoni F, Thornton JS.

PLoS One. 2016 Sep 20;11(9):e0162542. doi: 10.1371/journal.pone.0162542. eCollection 2016.

20.

HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yaldizli Ö, Sethi V, Pardini M, Tur C, Mok KY, Muhlert N, Liu Z, Samson RS, Wheeler-Kingshott CA, Yousry TA, Houlden H, Hardy J, Miller DH, Chard DT.

Mult Scler Relat Disord. 2016 May;7:47-52. doi: 10.1016/j.msard.2016.03.003. Epub 2016 Mar 7.

PMID:
27237756
21.

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study.

Gold R, Arnold DL, Bar-Or A, Hutchinson M, Kappos L, Havrdova E, MacManus DG, Yousry TA, Pozzilli C, Selmaj K, Sweetser MT, Zhang R, Yang M, Potts J, Novas M, Miller DH, Kurukulasuriya NC, Fox RJ, Phillips TJ.

Mult Scler. 2017 Feb;23(2):253-265. doi: 10.1177/1352458516649037. Epub 2016 Jul 11.

22.

Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.

Preziosa P, Rocca MA, Pagani E, Stromillo ML, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, Copetti M, De Stefano N, Fazekas F, Bisecco A, Barkhof F, Yousry TA, Arévalo MJ, Filippi M; MAGNIMS Study Group.

Hum Brain Mapp. 2016 Apr;37(4):1627-44. doi: 10.1002/hbm.23125. Epub 2016 Feb 2.

PMID:
26833969
23.

Muscle magnetic resonance imaging in congenital myasthenic syndromes.

Finlayson S, Morrow JM, Rodriguez Cruz PM, Sinclair CD, Fischmann A, Thornton JS, Knight S, Norbury R, White M, Al-Hajjar M, Carboni N, Jayawant S, Robb SA, Yousry TA, Beeson D, Palace J.

Muscle Nerve. 2016 Aug;54(2):211-9. doi: 10.1002/mus.25035. Epub 2016 Feb 22.

24.

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.

Morrow JM, Sinclair CD, Fischmann A, Machado PM, Reilly MM, Yousry TA, Thornton JS, Hanna MG.

Lancet Neurol. 2016 Jan;15(1):65-77. doi: 10.1016/S1474-4422(15)00242-2. Epub 2015 Nov 6.

25.

Deep brain stimulation of the subthalamic nucleus: histological verification and 9.4-T MRI correlation.

Al-Helli O, Thomas DL, Massey L, Foltynie T, Limousin P, Holton JL, Yousry TA, Zrinzo L.

Acta Neurochir (Wien). 2015 Dec;157(12):2143-7. doi: 10.1007/s00701-015-2599-x. Epub 2015 Oct 5.

PMID:
26438227
26.

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Wattjes MP, Rovira À, Miller D, Yousry TA, Sormani MP, de Stefano MP, Tintoré M, Auger C, Tur C, Filippi M, Rocca MA, Fazekas F, Kappos L, Polman C, Frederik Barkhof, Xavier Montalban; MAGNIMS study group.

Nat Rev Neurol. 2015 Oct;11(10):597-606. doi: 10.1038/nrneurol.2015.157. Epub 2015 Sep 15. Review.

PMID:
26369511
27.

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, De Stefano N, Filippi M, Auger C, Rocca MA, Barkhof F, Fazekas F, Kappos L, Polman C, Miller D, Montalban X; MAGNIMS study group.

Nat Rev Neurol. 2015 Aug;11(8):471-82. doi: 10.1038/nrneurol.2015.106. Epub 2015 Jul 7. Review. Erratum in: Nat Rev Neurol. 2015 Aug;11(8):483.

PMID:
26149978
28.

Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.

Yaldizli Ö, Pardini M, Sethi V, Muhlert N, Liu Z, Tozer DJ, Samson RS, Wheeler-Kingshott CA, Yousry TA, Miller DH, Chard DT.

Mult Scler. 2016 Feb;22(2):150-9. doi: 10.1177/1352458515586085. Epub 2015 May 26.

PMID:
26014608
29.

Extra-ocular muscle MRI in genetically-defined mitochondrial disease.

Pitceathly RD, Morrow JM, Sinclair CD, Woodward C, Sweeney MG, Rahman S, Plant GT, Ali N, Bremner F, Davagnanam I, Yousry TA, Hanna MG, Thornton JS.

Eur Radiol. 2016 Jan;26(1):130-7. doi: 10.1007/s00330-015-3801-5. Epub 2015 May 21.

30.

DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?

van de Pavert SH, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ridgway GR, Geurts JJ, Ron M, Yousry TA, Thompson AJ, Miller DH, Chard DT, Ciccarelli O.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):461-7. doi: 10.1136/jnnp-2014-310142. Epub 2015 Apr 29.

31.

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators.

Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.

32.

Preventing visual field deficits from neurosurgery.

Winston GP, Daga P, White MJ, Micallef C, Miserocchi A, Mancini L, Modat M, Stretton J, Sidhu MK, Symms MR, Lythgoe DJ, Thornton J, Yousry TA, Ourselin S, Duncan JS, McEvoy AW.

Neurology. 2014 Aug 12;83(7):604-11. doi: 10.1212/WNL.0000000000000685. Epub 2014 Jul 11.

33.

Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers.

Morrow JM, Sinclair CD, Fischmann A, Reilly MM, Hanna MG, Yousry TA, Thornton JS.

Eur Radiol. 2014 Jul;24(7):1610-20. doi: 10.1007/s00330-014-3145-6. Epub 2014 Apr 20.

34.

Automated identification of brain tumors from single MR images based on segmentation with refined patient-specific priors.

Sanjuán A, Price CJ, Mancini L, Josse G, Grogan A, Yamamoto AK, Geva S, Leff AP, Yousry TA, Seghier ML.

Front Neurosci. 2013 Dec 17;7:241. doi: 10.3389/fnins.2013.00241. eCollection 2013.

35.

MS cortical lesions on DIR: not quite what they seem?

Sethi V, Muhlert N, Ron M, Golay X, Wheeler-Kingshott CA, Miller DH, Chard DT, Yousry TA.

PLoS One. 2013 Nov 11;8(11):e78879. doi: 10.1371/journal.pone.0078879. eCollection 2013.

36.

Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias.

Morrow JM, Matthews E, Raja Rayan DL, Fischmann A, Sinclair CD, Reilly MM, Thornton JS, Hanna MG, Yousry TA.

Neuromuscul Disord. 2013 Aug;23(8):637-46. doi: 10.1016/j.nmd.2013.05.001. Epub 2013 Jun 27.

37.

Asymmetric sensory ganglionopathy: a case series.

Marquez-Infante C, Murphy SM, Mathew L, Alsanousi A, Lunn MP, Brandner S, Yousry TA, Blake J, Reilly MM.

Muscle Nerve. 2013 Jul;48(1):145-50. doi: 10.1002/mus.23772. Epub 2013 Jun 6.

PMID:
23744601
38.

Muscle MRI in Bethlem myopathy.

Morrow JM, Pitceathly RD, Quinlivan RM, Yousry TA.

BMJ Case Rep. 2013 Apr 16;2013. pii: bcr2013008596. doi: 10.1136/bcr-2013-008596. No abstract available.

39.

Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.

De Vita E, Ridgway GR, Scahill RI, Caine D, Rudge P, Yousry TA, Mead S, Collinge J, Jäger HR, Thornton JS, Hyare H.

AJNR Am J Neuroradiol. 2013 Sep;34(9):1723-30. doi: 10.3174/ajnr.A3504. Epub 2013 Mar 28.

40.

Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy.

Cottenie E, Menezes MP, Rossor AM, Morrow JM, Yousry TA, Dick DJ, Anderson JR, Jaunmuktane Z, Brandner S, Blake JC, Houlden H, Reilly MM.

Neuromuscul Disord. 2013 May;23(5):399-403. doi: 10.1016/j.nmd.2013.01.010. Epub 2013 Mar 13.

PMID:
23489662
41.

Strictly lobar microbleeds are associated with executive impairment in patients with ischemic stroke or transient ischemic attack.

Gregoire SM, Scheffler G, Jäger HR, Yousry TA, Brown MM, Kallis C, Cipolotti L, Werring DJ.

Stroke. 2013 May;44(5):1267-72. doi: 10.1161/STROKEAHA.111.000245. Epub 2013 Mar 12. Erratum in: Stroke. 2013 May;44(5):e62.

PMID:
23482601
42.

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, Filippi M.

Ann Neurol. 2012 Nov;72(5):779-87. doi: 10.1002/ana.23676.

PMID:
23280794
43.

Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.

Sethi V, Yousry TA, Muhlert N, Ron M, Golay X, Wheeler-Kingshott C, Miller DH, Chard DT.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):877-82. doi: 10.1136/jnnp-2012-303023. Epub 2012 Jul 17.

PMID:
22807559
44.

High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation.

Massey LA, Miranda MA, Zrinzo L, Al-Helli O, Parkes HG, Thornton JS, So PW, White MJ, Mancini L, Strand C, Holton JL, Hariz MI, Lees AJ, Revesz T, Yousry TA.

Neuroimage. 2012 Feb 1;59(3):2035-44. doi: 10.1016/j.neuroimage.2011.10.016. Epub 2011 Oct 21.

PMID:
22036997
45.

Diffusion tensor imaging tractography of the optic radiation for epilepsy surgical planning: a comparison of two methods.

Winston GP, Mancini L, Stretton J, Ashmore J, Symms MR, Duncan JS, Yousry TA.

Epilepsy Res. 2011 Nov;97(1-2):124-32. doi: 10.1016/j.eplepsyres.2011.07.019. Epub 2011 Sep 1.

46.

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.

Kappos L, Gold R, Miller DH, MacManus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Eraksoy M, Meluzinova E, Dufek M, Yang M, Dawson K, O'Neill GN.

Mult Scler. 2012 Mar;18(3):314-21. doi: 10.1177/1352458511421054. Epub 2011 Aug 30.

PMID:
21878455
47.

Clinical safety of brain magnetic resonance imaging with implanted deep brain stimulation hardware: large case series and review of the literature.

Zrinzo L, Yoshida F, Hariz MI, Thornton J, Foltynie T, Yousry TA, Limousin P.

World Neurosurg. 2011 Jul-Aug;76(1-2):164-72; discussion 69-73. doi: 10.1016/j.wneu.2011.02.029.

PMID:
21839969
48.

Correcting radiofrequency inhomogeneity effects in skeletal muscle magnetisation transfer maps.

Sinclair CD, Morrow JM, Hanna MG, Reilly MM, Yousry TA, Golay X, Thornton JS.

NMR Biomed. 2012 Feb;25(2):262-70. doi: 10.1002/nbm.1744. Epub 2011 Jul 27.

PMID:
21796708
49.

Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson's disease.

Pinto S, Mancini L, Jahanshahi M, Thornton JS, Tripoliti E, Yousry TA, Limousin P.

Mov Disord. 2011 Oct;26(12):2212-9. doi: 10.1002/mds.23799. Epub 2011 Jun 28.

50.

Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.

Berg D, Steinberger JD, Warren Olanow C, Naidich TP, Yousry TA.

Mov Disord. 2011 May;26(6):979-92. doi: 10.1002/mds.23766. Review. Erratum in: Mov Disord. 2011 Jun;26(7):1372.

PMID:
21626543

Supplemental Content

Loading ...
Support Center